BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 151.4 SEK 6.39% Market Closed
Market Cap: 13.4B SEK
Have any thoughts about
BioArctic AB?
Write Note

Relative Value

The Relative Value of one BIOA B stock under the Base Case scenario is 151.12 SEK. Compared to the current market price of 151.4 SEK, BioArctic AB is Fairly Valued.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOA B Relative Value
Base Case
151.12 SEK
Fairly Valued
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
18
Median 3Y
75.4
Median 5Y
86.6
Industry
8.1
Forward
47.1
vs History
vs Industry
2
Median 3Y
-63.4
Median 5Y
-109.4
Industry
23
Forward
-75.2
vs History
vs Industry
3
Median 3Y
-69.7
Median 5Y
-82.9
Industry
23.4
vs History
vs Industry
2
Median 3Y
-66.5
Median 5Y
-74.5
Industry
27.3
vs History
46
vs Industry
4
Median 3Y
18.1
Median 5Y
13.3
Industry
2.6
vs History
66
vs Industry
14
Median 3Y
73.5
Median 5Y
76.4
Industry
8.1
Forward
45.5
vs History
50
vs Industry
9
Median 3Y
46.3
Median 5Y
48.9
Industry
9.6
vs History
vs Industry
2
Median 3Y
-37
Median 5Y
-63.6
Industry
4.3
Forward
-52.9
vs History
vs Industry
1
Median 3Y
-51.3
Median 5Y
-75.3
Industry
3.8
Forward
-61.9
vs History
vs Industry
2
Median 3Y
-63.7
Median 5Y
-74.2
Industry
6
vs History
vs Industry
3
Median 3Y
-61.8
Median 5Y
-70.7
Industry
3.8
vs History
96
vs Industry
9
Median 3Y
189.3
Median 5Y
152.2
Industry
4.8

Multiples Across Competitors

BIOA B Competitors Multiples
BioArctic AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
BioArctic AB
STO:BIOA B
13.4B SEK 44.7 -151.5 -134.7 -134.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
SE
BioArctic AB
STO:BIOA B
Average P/E: 213.3
Negative Multiple: -151.5
192%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
SE
BioArctic AB
STO:BIOA B
Average EV/EBITDA: 18
Negative Multiple: -134.7
270%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
SE
BioArctic AB
STO:BIOA B
Average EV/EBIT: 23.4
Negative Multiple: -134.7
201%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top